{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:45:22Z","timestamp":1789397122962,"version":"build-2803163510"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022571","name":"Institute of Pharmacy, Nirma University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018502","name":"Kanazawa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.bbalip.2012.06.008","type":"journal-article","created":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T11:45:34Z","timestamp":1340451934000},"page":"185-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases"],"prefix":"10.1016","volume":"1831","author":[{"given":"Yoh","family":"Takuwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Takuwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2012.06.008_bb0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases","volume":"117","author":"Wynn","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cardiores.2004.08.020","article-title":"Structural and functional characterization of cardiac fibroblasts","volume":"65","author":"Camelliti","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0015","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.pharmtox.45.120403.095802","article-title":"The cardiac fibroblast: Therapeutic target in myocardial remodeling and failure","volume":"45","author":"Brown","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0020","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","article-title":"Cardiac fibroblasts: At the heart of myocardial remodeling","volume":"123","author":"Porter","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0030","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.humpath.2009.02.020","article-title":"Direct contribution to organ fibrosis: epithelial-mesenchymal transition","volume":"40","author":"Guarino","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1083\/jcb.114.1.155","article-title":"Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation","volume":"114","author":"Zhang","year":"1991","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0040","doi-asserted-by":"crossref","first-page":"9686","DOI":"10.1073\/pnas.89.20.9686","article-title":"Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness","volume":"89","author":"Sadahira","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0045","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1126\/science.1057559","article-title":"Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility","volume":"291","author":"Hobson","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2353\/ajpath.2007.060485","article-title":"Immunomodulator FTY720 induced myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling","volume":"170","author":"Keller","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri2974","article-title":"The outs and the ins of sphingosine-1-phosphate in immunity","volume":"11","author":"Spiegel","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cvr\/cvp086","article-title":"Sphingosine-1-phosphate receptor signalling in the heart","volume":"82","author":"Means","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0065","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1124\/jpet.103.062828","article-title":"Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes","volume":"309","author":"Forrest","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0075","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/CIRCULATIONAHA.105.607135","article-title":"High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia\/reperfusion injury in vivo via the S1P3 lysophospholipid receptor","volume":"114","author":"Theilmeier","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/hh0302.104455","article-title":"Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively Regulates cellular Rac activity and cell migration in vascular smooth muscle cells","volume":"90","author":"Ryu","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/biof.1030","article-title":"Sphingosine-1-phosphate signaling in physiology and diseases","author":"Takuwa","year":"2012","journal-title":"BioFactors"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1476-5381.2010.00878.x","article-title":"Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery","volume":"161","author":"Mair","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0095","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1161\/01.CIR.0000147827.43912.AE","article-title":"lipoprotein stimulates myocardial perfusion in vivo","volume":"110","author":"Levkau","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cvr\/cvp070","article-title":"Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection","volume":"82","author":"Sattler","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/FJC.0b013e3181926706","article-title":"Sphingosine kinase and sphingosine 1-phosphate in cardioprotection","volume":"53","author":"Karliner","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0115","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1006\/jmcc.2001.1429","article-title":"The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes","volume":"33","author":"Karliner","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0120","doi-asserted-by":"crossref","first-page":"H1970","DOI":"10.1152\/ajpheart.01029.2001","article-title":"Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts","volume":"282","author":"Jin","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0125","doi-asserted-by":"crossref","first-page":"H2944","DOI":"10.1152\/ajpheart.01331.2006","article-title":"Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury","volume":"292","author":"Means","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cardiores.2007.05.029","article-title":"A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia\/reperfusion injury","volume":"76","author":"Jin","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0135","doi-asserted-by":"crossref","first-page":"961059","DOI":"10.1155\/2011\/961059","article-title":"A Sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia\/reoxygenation injury and diminishes responsiveness to ischemic preconditioning","volume":"2011","author":"Vessey","year":"2011","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0140","doi-asserted-by":"crossref","first-page":"H1429","DOI":"10.1152\/ajpheart.00358.2009","article-title":"Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning","volume":"297","author":"Vessey","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0145","doi-asserted-by":"crossref","first-page":"H1753","DOI":"10.1152\/ajpheart.00946.2010","article-title":"S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart","volume":"300","author":"Jin","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0150","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/01.CIR.0000085658.98621.49","article-title":"Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?","volume":"108","author":"Jugdutt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0012-1606(84)90038-1","article-title":"Recognition of extracellular matrix components by neonatal and adult cardiac myocytes","volume":"104","author":"Borg","year":"1984","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0160","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0014-4827(69)90029-9","article-title":"Synchronized beating of embryonicmousemyocardial cells mediated by FL cells in monolayer culture","volume":"56","author":"Goshima","year":"1969","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1113\/jphysiol.2007.135038","article-title":"Evidence of intercellular coupling between co-cultured adult rabbit ventricular myocytes and myofibroblasts","volume":"583","author":"Chilton","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0170","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","article-title":"Cardiac fibroblasts: at the heart of myocardial remodeling","volume":"123","author":"Porter","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0175","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1152\/physrev.00006.2003","article-title":"Cardiac chamber formation: development, genes, and evolution","volume":"83","author":"Moorman","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0180","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/cvr\/cvq308","article-title":"Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart","volume":"89","author":"Creemers","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","article-title":"TGF-\u03b21 and angiotensin networking in cardiac remodeling","volume":"63","author":"Rosenkranz","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0190","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI0214190","article-title":"TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II","volume":"109","author":"Schultz","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0195","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0008-6363(01)00540-5","article-title":"Impact of HMG CoA reductase inhibition on small GTPases in the heart","volume":"53","author":"Laufs","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0200","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/01.RES.0000204727.46710.5e","article-title":"Regulation of NADPH oxidases: the role of Rac proteins","volume":"98","author":"Hordijk","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0205","doi-asserted-by":"crossref","first-page":"C1181","DOI":"10.1152\/ajpcell.00328.2010","article-title":"Angiotensin II-induced vascular endothelial dysfunction through RhoA\/Rho kinase\/p38 mitogen-activated protein kinase\/arginase pathway","volume":"300","author":"Shatanawi","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0210","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/cvr\/cvp312","article-title":"S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species","volume":"85","author":"Takuwa","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0215","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1388-1981(02)00145-2","article-title":"Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors","volume":"1582","author":"Takuwa","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0220","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbalip.2008.04.003","article-title":"Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system","volume":"1781","author":"Takuwa","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0225","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/01.RES.0000216039.75913.9e","article-title":"The Rac and Rho hall of fame: a decade of hypertrophic signaling hits","volume":"98","author":"Brown","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2353\/ajpath.2007.060485","article-title":"Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling","volume":"170","author":"Keller","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0235","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1091\/mbc.e09-09-0812","article-title":"Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1\/S1P3 axis","volume":"21","author":"Cencetti","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0240","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/cvr\/cvp056","article-title":"Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts","volume":"82","author":"Gellings Lowe","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0245","first-page":"60052","article-title":"Idiopathic pulmonary fibrosis","volume":"6736","author":"King","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0250","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1378\/chest.09-0510","article-title":"New mechanisms of pulmonary fibrosis","volume":"136","author":"Strieter","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0255","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1513\/pats.200711-168DR","article-title":"Fibrogenesis of parencymal organs","volume":"5","author":"Kisseleva","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0260","first-page":"L1110","article-title":"Choride channel activity in human lung fibroblasts and myofibroblasts","volume":"288","author":"Yin","year":"2005","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nm1685","article-title":"The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak","volume":"14","author":"Tager","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0270","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1165\/rcmb.2010-0155OC","article-title":"The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury","volume":"46","author":"Funke","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0275","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbrc.2011.04.084","article-title":"Blockade of lysophosphatidic acid receptors LPAR1\/3 ameliorates lung fibrosis induced by irradiation","volume":"409","author":"Gan","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0280","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2353\/ajpath.2009.080160","article-title":"Lysophosphatidic acid induces \u03b1v\u03b26 integrin-mediated TGF-\u03b2activation via the LPA2 receptor and the small G protein G\u03b1q","volume":"174","author":"Xu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0285","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1476-5381.2010.00828.x","article-title":"A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model","volume":"160","author":"Swaney","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0290","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1124\/jpet.110.175901","article-title":"Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type LPA1 receptor-selective antagonist","volume":"336","author":"Swaney","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0300","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1159\/000322342","article-title":"Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice","volume":"26","author":"Dhami","year":"2010","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0305","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1165\/rcmb.2007-0065OC","article-title":"Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-\u03b21","volume":"37","author":"Kono","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0310","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/thoraxjnl-2011-200026","article-title":"Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition","volume":"67","author":"Milara","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0315","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1165\/rcmb.2006-0427OC","article-title":"Sphingsine 1-phosphate potentiates human lung fibroblast chemotaxis through the S1P2 receptor","volume":"39","author":"Hashimoto","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0320","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1128\/MCB.25.10.4237-4249.2005","article-title":"The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation","volume":"25","author":"Goparaju","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0325","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.prostaglandins.2006.05.001","article-title":"The functional PDGF\u03b2 receptor-S1P1 receptor signaling complex is involved in regulating migration of mouse embryonic fibroblasts in response to platelet derived growth factor","volume":"80","author":"Long","year":"2006","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0330","first-page":"17","article-title":"Sphingosine 1-phosphate induces alpha-smooth muscle actin expression in lung fibroblasts via Rho-kinase","volume":"51","author":"Urata","year":"2005","journal-title":"Kobe J. Med. Sci."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0335","first-page":"A2152","article-title":"Sphingosine kinase 1 deficiency protects bleomycin induced mouse lung fibrosis","volume":"183","author":"Hunag","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0340","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1172\/JCI12450","article-title":"Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement","volume":"108","author":"Garcia","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0345","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1165\/rcmb.2009-0345OC","article-title":"Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury","volume":"43","author":"Shea","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0350","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrd2356","article-title":"Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules","volume":"8","author":"Marsolais","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0355","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI45403","article-title":"Engagement of S1P\u2081-degradative mechanisms leads to vascular leak in mice","volume":"121","author":"Oo","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0360","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0365","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7150\/ijms.6.168","article-title":"Elevated serum levels of arachidonoyl-lysophosphatidic acid and sphingosine 1-phosphate in systemic sclerosis","volume":"6","author":"Tokumura","year":"2009","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0370","first-page":"161","article-title":"A role for lysophosphatidic acid and sphingosine 1-phosphate in the pathogenesis of systemic sclerosis","volume":"10","author":"Pattanaik","year":"2010","journal-title":"Discov. Med."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0375","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/rheumatology\/keq260","article-title":"Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts","volume":"49","author":"Yin","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0380","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/art.27463","article-title":"Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-beta\/Smad signaling are mediated through the PTEN\/PPM1A-dependent pathway","volume":"62","author":"Bu","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0385","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/art.30262","article-title":"Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma","volume":"63","author":"Castelino","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0390","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1476-5381.2011.01622.x","article-title":"Insights into the pharmacological relevance of lysophospholipid receptors","volume":"165","author":"Mutoh","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0395","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1172\/JCI116769","article-title":"Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo","volume":"92","author":"Rockey","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0400","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/hep.510290640","article-title":"In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation","volume":"29","author":"Ikeda","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0405","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0410","doi-asserted-by":"crossref","first-page":"G304","DOI":"10.1152\/ajpgi.2000.279.2.G304","article-title":"Biological activities of novel lipid mediator sphingosine 1-phosphate in rat hepatic stellate cells","volume":"279","author":"Ikeda","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0415","doi-asserted-by":"crossref","first-page":"34628","DOI":"10.1074\/jbc.M006393200","article-title":"Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts. A cyclooxygenase-2 mediated pathway","volume":"275","author":"Davaille","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0420","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbalip.2008.03.004","article-title":"Biological roles of lysophospholipid receptors revealed by genetic null mice: an update","volume":"1781","author":"Choi","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0425","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1096\/fj.06-6889com","article-title":"The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing","volume":"21","author":"Serriere-Lanneau","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0430","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1194\/jlr.M800496-JLR200","article-title":"Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2","volume":"50","author":"Ikeda","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0435","doi-asserted-by":"crossref","first-page":"9247","DOI":"10.1128\/MCB.20.24.9247-9261.2000","article-title":"Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3","volume":"20","author":"Okamoto","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0440","doi-asserted-by":"crossref","DOI":"10.1002\/hep.25780","article-title":"Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rats","author":"Kegeyama","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0445","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1872-034X.2012.00978.x","article-title":"Interplay between bone marrow and liver in the pathogenesis of hepatic fibrosis","volume":"20","author":"Inagaki","year":"2012","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0450","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2353\/ajpath.2009.090037","article-title":"Involvement of sphingosine 1-phosphate (SIP)\/S1P3 signaling in cholestasis-induced liver fibrosis","volume":"175","author":"Li","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0455","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jhep.2009.01.028","article-title":"Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis","volume":"50","author":"Li","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0460","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jhep.2010.08.028","article-title":"Sphingosine 1-phosphate (S1P)\/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility","volume":"54","author":"Li","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0465","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/jcp.22572","article-title":"Essential roles of sphingosine 1-phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation","volume":"226","author":"Liu","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0470","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bbrc.2004.04.207","article-title":"Sphingosine 1-phosphate enhances portal pressure in isolated perfused liver via S1P2 with Rho activation","volume":"320","author":"Ikeda","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2012.06.008_bb0475","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cca.2010.02.063","article-title":"Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C","volume":"411","author":"Ikeda","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0480","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1182\/blood.V86.1.193.bloodjournal861193","article-title":"Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets","volume":"86","author":"Yatomi","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbalip.2012.06.008_bb0485","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1126\/science.1139221","article-title":"Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate","volume":"316","author":"Pappu","year":"2007","journal-title":"Science"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198112001217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198112001217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T09:57:13Z","timestamp":1761386233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198112001217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1388198112001217"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2012.06.008","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2012.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}